Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Acta Pharmaceutica
Volume 73 (2023): Issue 3 (September 2023)
Open Access
Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis
Haibo Liu
Haibo Liu
,
Shicheng Luo
Shicheng Luo
,
Xiaofeng Sha
Xiaofeng Sha
,
Zhiping Chen
Zhiping Chen
and
Dongdong Yang
Dongdong Yang
| Sep 14, 2023
Acta Pharmaceutica
Volume 73 (2023): Issue 3 (September 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Published Online:
Sep 14, 2023
Page range:
423 - 439
Accepted:
Jul 30, 2023
DOI:
https://doi.org/10.2478/acph-2023-0033
Keywords
astragaloside IV
,
cancer-associated fibroblasts
,
HOXA6
,
ZBTB12
© 2023 Haibo Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.